SPY317.05+4.82 1.54%
DIA263.00+4.58 1.77%
IXIC10,433.65+226.02 2.21%

Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $195

Canaccord Genuity maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $185 to $195.

Benzinga · -

Canaccord Genuity maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $185 to $195.